These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 17967156)

  • 21. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.
    Chalasani NP; Hayashi PH; Bonkovsky HL; Navarro VJ; Lee WM; Fontana RJ;
    Am J Gastroenterol; 2014 Jul; 109(7):950-66; quiz 967. PubMed ID: 24935270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury.
    Fontana RJ; Bjornsson ES; Reddy R; Andrade RJ
    Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2088-2099. PubMed ID: 36868489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.
    Moreno-Torres M; Quintás G; Martínez-Sena T; Jover R; Castell JV
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of immune reactions in drug-induced liver injury (DILI).
    Ju C; Reilly T
    Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
    Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced liver injury.
    Abboud G; Kaplowitz N
    Drug Saf; 2007; 30(4):277-94. PubMed ID: 17408305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
    Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
    Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
    Alhaddad O; Elsabaawy M; Abdelsameea E; Abdallah A; Shabaan A; Ehsan N; Elrefaey A; Elsabaawy D; Salama M
    Sci Rep; 2020 Mar; 10(1):5124. PubMed ID: 32198411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Models of Idiosyncratic Drug-Induced Liver Injury.
    Yokoi T; Oda S
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():247-268. PubMed ID: 32976738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced liver injury due to antibiotics.
    Björnsson ES
    Scand J Gastroenterol; 2017; 52(6-7):617-623. PubMed ID: 28276834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
    Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
    Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
    Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
    Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
    Björnsson E; Jacobsen EI; Kalaitzakis E
    J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
    Chalasani N; Fontana RJ; Bonkovsky HL; Watkins PB; Davern T; Serrano J; Yang H; Rochon J;
    Gastroenterology; 2008 Dec; 135(6):1924-34, 1934.e1-4. PubMed ID: 18955056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity?
    Boelsterli UA; Lim PL
    Toxicol Appl Pharmacol; 2007 Apr; 220(1):92-107. PubMed ID: 17275868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced liver injury.
    Katarey D; Verma S
    Clin Med (Lond); 2016 Dec; 16(Suppl 6):s104-s109. PubMed ID: 27956449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.